372 related articles for article (PubMed ID: 23391324)
41. Serum microRNAs as diagnostic markers of endometriosis: a comprehensive array-based analysis.
Cosar E; Mamillapalli R; Ersoy GS; Cho S; Seifer B; Taylor HS
Fertil Steril; 2016 Aug; 106(2):402-9. PubMed ID: 27179784
[TBL] [Abstract][Full Text] [Related]
42. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C
Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286
[TBL] [Abstract][Full Text] [Related]
43. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
44. Detection of microRNA as novel biomarkers of epithelial ovarian cancer from the serum of ovarian cancer patients.
Chung YW; Bae HS; Song JY; Lee JK; Lee NW; Kim T; Lee KW
Int J Gynecol Cancer; 2013 May; 23(4):673-9. PubMed ID: 23542579
[TBL] [Abstract][Full Text] [Related]
45. Circulating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture.
Supriya M; Christopher R; Indira Devi B; Bhat DI; Shukla D
Mol Diagn Ther; 2020 Jun; 24(3):351-364. PubMed ID: 32323261
[TBL] [Abstract][Full Text] [Related]
46. High serum extracellular vesicle miR-10b expression predicts poor prognosis in patients with acute myeloid leukemia.
Fang Z; Wang X; Wu J; Xiao R; Liu J
Cancer Biomark; 2020; 27(1):1-9. PubMed ID: 31594209
[TBL] [Abstract][Full Text] [Related]
47. Serum miR-133 as a novel biomarker for predicting treatment response and survival in acute myeloid leukemia.
Zheng ZZ; Ma YP; Wu RH; Rong G; Li C; Li GX; Ren FG; Xu LJ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):777-783. PubMed ID: 32016982
[TBL] [Abstract][Full Text] [Related]
48. Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.
Lian F; Cui Y; Zhou C; Gao K; Wu L
PLoS One; 2015; 10(3):e0121499. PubMed ID: 25775010
[TBL] [Abstract][Full Text] [Related]
49. Altered serum microRNAs as novel diagnostic biomarkers for atypical coronary artery disease.
Wang J; Pei Y; Zhong Y; Jiang S; Shao J; Gong J
PLoS One; 2014; 9(9):e107012. PubMed ID: 25198728
[TBL] [Abstract][Full Text] [Related]
50. Serum microRNA expression profile as a diagnostic panel for gastric cancer.
Huang S; Wang J; Li J; Luo Q; Zhao M; Zheng L; Dong X; Chen C; Che Y; Liu P; Qi J; Huang C
Jpn J Clin Oncol; 2016 Sep; 46(9):811-8. PubMed ID: 27380811
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA-223 and miR-143 are important systemic biomarkers for disease activity in psoriasis.
Løvendorf MB; Zibert JR; Gyldenløve M; Røpke MA; Skov L
J Dermatol Sci; 2014 Aug; 75(2):133-9. PubMed ID: 24909097
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis.
Zou X; Zhu D; Zhang H; Zhang S; Zhou X; He X; Zhu J; Zhu W
Gene; 2020 Feb; 727():144243. PubMed ID: 31743768
[TBL] [Abstract][Full Text] [Related]
53. Clinical significance of dysregulation of miR-381 in pediatric acute myeloid leukemia.
Zhang P; Sun D; Sun X; Li H
Eur J Med Res; 2020 Sep; 25(1):42. PubMed ID: 32938467
[TBL] [Abstract][Full Text] [Related]
54. Potential circulating miRNA signature for early detection of NSCLC.
Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
[TBL] [Abstract][Full Text] [Related]
55. Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia.
Liu L; Chen R; Zhang Y; Fan W; Xiao F; Yan X
Diagn Pathol; 2015 Jul; 10():109. PubMed ID: 26185105
[TBL] [Abstract][Full Text] [Related]
56. MicroRNA 628-5p as a Novel Biomarker for Cardiac Allograft Vasculopathy.
Neumann A; Napp LC; Kleeberger JA; Benecke N; Pfanne A; Haverich A; Thum T; Bara C
Transplantation; 2017 Jan; 101(1):e26-e33. PubMed ID: 27653298
[TBL] [Abstract][Full Text] [Related]
57. Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers.
Bononi I; Comar M; Puozzo A; Stendardo M; Boschetto P; Orecchia S; Libener R; Guaschino R; Pietrobon S; Ferracin M; Negrini M; Martini F; Bovenzi M; Tognon M
Oncotarget; 2016 Dec; 7(50):82700-82711. PubMed ID: 27716620
[TBL] [Abstract][Full Text] [Related]
58. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
59. Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer.
Valladares-Ayerbes M; Reboredo M; Medina-Villaamil V; Iglesias-Díaz P; Lorenzo-Patiño MJ; Haz M; Santamarina I; Blanco M; Fernández-Tajes J; Quindós M; Carral A; Figueroa A; Antón-Aparicio LM; Calvo L
J Transl Med; 2012 Sep; 10():186. PubMed ID: 22954417
[TBL] [Abstract][Full Text] [Related]
60. miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma.
Lou N; Ruan AM; Qiu B; Bao L; Xu YC; Zhao Y; Sun RL; Zhang ST; Xu GH; Ruan HL; Yuan CF; Han WW; Shi HC; Yang HM; Zhang XP
Urol Oncol; 2017 Jan; 35(1):36.e7-36.e14. PubMed ID: 27633984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
